Company News
Wednesday preview: EU summit and ECB rate decision in focus
Investors would do well to ready themselves for an intense day with several key risks events and a barrage of top-tier economic data ahead of them, alongside a substantial pick up in the flow of corporate updates.
ReNeuron soars after partnering with Chinese pharma giant
ReNeuron's shares soared on Tuesday after it signed an exclusive licence agreement with Shanghai Fosun Pharmaceutical Industrial Development (SFPID) for the development, manufacture and commercialisation of ReNeuron's cell therapy programmes in China.
Sports Direct extends Findel offer deadline
Mike Ashley's Sports Direct has upped its holding in Findel and extended its offer for the home shopping company.
Debenhams calls in administrators, operations sold to lenders
Debenhams called in the administrators just before midday on Tuesday, with the entire underlying operating company immediately sold to the departments store group's lenders.
Gooch & Housego expecting bigger second half
Specialist manufacturer of photonic components and systems Gooch & Housego told the market on Tuesday that trading in the six months to 31 March was in line with its expectations.
Active Energy joint venture unsuccessful in bid for EU grant
Renewable energy and forestry management company Active Energy Group updated the market on Tuesday, on the activities of AEG CEE - the joint venture company formed in March last year with Polish research, development and environmental waste coal recovery company Cobant.
Inland Homes sells Dagenham site to Clarion Housing Group
Specialist brownfield land developer and housebuilder Inland Homes has exchanged contracts for the sale and related development contract for its Merrielands Crescent site in Dagenham, East London with the Clarion Housing Group housing association, it announced on Tuesday.
StanChart settles with UK and US regulators for over $1bn
StanChart will pay just over $1bn to settle two probes with US and British regulators, respectively, relating to the violation of US sanctions against Iran between 2001 and 2014 and the alleged inadequacies of its internal controls.
Tom Oakley elevated to group CEO at Feedback
Specialist medical imaging technology company Feedback has appointed Dr Tom Oakley as its chief executive officer with immediate effect, it announced on Tuesday.
Barclays cuts UK back office jobs
Birmingham Snowhillplans to cut around 460 jobs from its UK offices, including Canary Wharf, Birmingham Snowhill and Coventry Westwood Park.
Drilling rig contracted for i3 Energy summer campaign
Independent UK-focussed oil and gas company i3 Energy updated the market on the appraisal and development of its 100% owned-and-operated Liberator field and Serenity prospect on Tuesday, confirming it had contracted the Borgland Dolphin semi-submersible drilling rig for the summer drilling campaign.
Defenx enters into new agreements with majority shareholder BV Tech
Cybersecurity software group Defenx has entered into a software distribution agreement and a software services agreement with its majority shareholder BV Tech, it announced on Tuesday.
OptiBiotix Health signs distribution agreement for SlimBiome in Bulgaria
Life sciences business OptiBiotix Health has entered into a three-year distribution agreement with an unnamed “established and recognised” company, it announced on Tuesday, to exclusively distribute and commercialise its CE-marked medical device ‘SlimBiome Medical’ in Bulgaria.
One Media iP revenue and earnings rise as music industry sees growth
Music, video and copyright technology intellectual property rights company One Media iP reported a 16% improvement in revenue in its full-year results on Tuesday, to £2. 7m.
Comptoir swings to loss as costs bite
Comptoir Group on Tuesday swung to an annual loss as a jump in revenue was offset by increased costs as the company warned of "unprecedented political and general uncertainty".
Sosandar revenues soar as new and repeat customer numbers improve
Online women's fashion brand Sosandar expects to turn in significantly improved revenues from its last trading year, comfortably in line with market expectations.
Avacta falls as stuttering revenues exacerbate losses
Avacta Group's shares slid on Tuesday as interim revenues dropped on the back of a lower contribution from the life sciences division, which resulted in wider losses.
Anexo beats market expectations as revenues leap
Anexo Group's shares climbed on Tuesday as it reported that annual revenues soared, but profit before tax remained largely flat as cost of sales and administrative expenses moved higher in tandem.
Morgan Stanley downgrades Hays amid lack of near-term catalysts
Morgan Stanley downgraded its rating on the shares of recruiter Hays to 'equalweight' from 'overweight' on Tuesday as it highlighted a lack of near-term catalysts.
Nuformix inks cannabinoid therapeutics deal with Ebers Tech
Pharmaceutical development company Nuformix has inked an agreement for cannabinoid therapeutics development, licensing and commercialisation with Canadian outfit Ebers Tech.